BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 17227304)

  • 1. Concurrent chemoradiation for patients with squamous cell carcinoma of the cervical esophagus.
    Uno T; Isobe K; Kawakami H; Ueno N; Shimada H; Matsubara H; Okazumi S; Nabeya Y; Shiratori T; Kawata T; Ochiai T; Ito H
    Dis Esophagus; 2007; 20(1):12-8. PubMed ID: 17227304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resectable esophageal carcinoma: local control with neoadjuvant chemotherapy and radiation therapy.
    Chidel MA; Rice TW; Adelstein DJ; Kupelian PA; Suh JH; Becker M
    Radiology; 1999 Oct; 213(1):67-72. PubMed ID: 10540642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retrospective analysis of outcome differences in preoperative concurrent chemoradiation with or without elective nodal irradiation for esophageal squamous cell carcinoma.
    Hsu FM; Lee JM; Huang PM; Lin CC; Hsu CH; Tsai YC; Lee YC; Chia-Hsien Cheng J
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e593-9. PubMed ID: 21658851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant chemotherapy after esophagectomy: is there a role in the treatment of the lymph node positive thoracic esophageal squamous cell carcinoma?
    Lyu X; Huang J; Mao Y; Liu Y; Feng Q; Shao K; Gao S; Jiang Y; Wang J; He J
    J Surg Oncol; 2014 Dec; 110(7):864-8. PubMed ID: 24976079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.
    Liao Z; Zhang Z; Jin J; Ajani JA; Swisher SG; Stevens CW; Ho L; Smythe R; Vaporciyan AA; Putnam JB; Walsh GL; Roth JA; Yao JC; Allen PK; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1484-93. PubMed ID: 15590179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphism in epidermal growth factor receptor intron 1 predicts prognosis of patients with esophageal cancer after chemoradiation and surgery.
    Lee JM; Yang SY; Yang PW; Shun CT; Wu MT; Hsu CH; Lin CC; Cheng JC; Wang YH; Chuang TH; Chen JS; Hsu HH; Huang PM; Kuo SW; Lee YC
    Ann Surg Oncol; 2011 Jul; 18(7):2066-73. PubMed ID: 21298351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. REG1A expression status suggests chemosensitivity among advanced thoracic esophageal squamous cell carcinoma patients treated with esophagectomy followed by adjuvant chemotherapy.
    Sato Y; Motoyama S; Nanjo H; Ito S; Yoshino K; Sasaki T; Kuribayashi K; Nagaki Y; Imai K; Saito H; Minamiya Y; Ogawa J
    Ann Surg Oncol; 2013 Sep; 20(9):3044-51. PubMed ID: 23645481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concurrent chemoradiotherapy for locally advanced esophageal cancer--a pilot study by using daily low-dose cisplatin and continuous infusion of 5-fluorouracil.
    Hsu CH; Yeh KH; Lui LT; Lee YC; Bu CF; Wang HP; Lin JT; Cheng AL
    Anticancer Res; 1999; 19(5C):4463-7. PubMed ID: 10650793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High serum levels of vascular endothelial growth factor-A and transforming growth factor-β1 before neoadjuvant chemoradiotherapy predict poor outcomes in patients with esophageal squamous cell carcinoma receiving combined modality therapy.
    Cheng JC; Graber MS; Hsu FM; Tsai CL; Castaneda L; Lee JM; Chang DT; Koong AC
    Ann Surg Oncol; 2014 Jul; 21(7):2361-8. PubMed ID: 24623035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concurrent radiation therapy and chemotherapy followed by esophagectomy for localized esophageal carcinoma.
    Bates BA; Detterbeck FC; Bernard SA; Qaqish BF; Tepper JE
    J Clin Oncol; 1996 Jan; 14(1):156-63. PubMed ID: 8558191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management for patients with advanced T4 epidermoid carcinoma of the esophagus.
    Wang LS; Chi KH; Hu MH; Fahn HJ; Huang MH
    J Surg Oncol; 1996 May; 62(1):22-9. PubMed ID: 8618396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three-dimensional conformal radiotherapy with concurrent chemotherapy for postoperative recurrence of esophageal squamous cell carcinoma: clinical efficacy and failure pattern.
    Bao Y; Liu S; Zhou Q; Cai P; Anfossi S; Li Q; Hu Y; Liu M; Fu J; Rong T; Li Q; Liu H
    Radiat Oncol; 2013 Oct; 8():241. PubMed ID: 24139225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of Survival in Esophageal Squamous Cell Carcinoma with Pathologic Major Response after Neoadjuvant Chemoradiation Therapy and Surgery: The Impact of Chemotherapy Protocols.
    Li CY; Huang PM; Chu PY; Chen PM; Lin MW; Kuo SW; Lee JM
    Biomed Res Int; 2016; 2016():6423297. PubMed ID: 27777949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of concurrent chemoradiotherapy versus chemotherapy alone for stage IV esophageal squamous cell carcinoma: a retrospective controlled study.
    Lyu J; Li T; Wang Q; Li F; Diao P; Liu L; Li C; Lang J
    Radiat Oncol; 2018 Nov; 13(1):233. PubMed ID: 30477531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Squamous cell carcinoma of the esophagus infiltrating the respiratory tract is less sensitive to preoperative concurrent radiation and chemotherapy.
    Yano M; Shiozaki H; Tsujinaka T; Inoue M; Doki Y; Fujiwara Y; Monden M
    J Am Coll Surg; 2000 Dec; 191(6):626-34. PubMed ID: 11129811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term results of definitive radiochemotherapy in locally advanced cancers of the cervical esophagus.
    Gkika E; Gauler T; Eberhardt W; Stahl M; Stuschke M; Pöttgen C
    Dis Esophagus; 2014; 27(7):678-84. PubMed ID: 24147973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of induction concurrent chemoradiotherapy on pulmonary function and postoperative acute respiratory complications in esophageal cancer.
    Abou-Jawde RM; Mekhail T; Adelstein DJ; Rybicki LA; Mazzone PJ; Caroll MA; Rice TW
    Chest; 2005 Jul; 128(1):250-5. PubMed ID: 16002943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do We Need to Add Postoperative Radiotherapy in Patients Undergoing Trimodality Therapy for Esophageal Squamous Cell Carcinoma with Positive Lymph Nodes Disease?
    Huang PM; Hsu FM; Lin CC; Hsu CH; Cheng JC; Lee JM
    Dig Surg; 2018; 35(2):104-110. PubMed ID: 28675905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platinum-based combination chemotherapy vs. weekly cisplatin during adjuvant CCRT in early cervical cancer with pelvic LN metastasis.
    Lee YY; Park W; Huh SJ; Yoon A; Park JY; Choi CH; Kim TJ; Lee JW; Kim BG; Bae DS
    Anticancer Res; 2013 Oct; 33(10):4675-81. PubMed ID: 24123048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nodal metastasis from locally advanced esophageal cancer: how neoadjuvant therapy modifies their frequency and distribution.
    Castoro C; Scarpa M; Cagol M; Ruol A; Cavallin F; Alfieri R; Zanchettin G; Rugge M; Ancona E
    Ann Surg Oncol; 2011 Dec; 18(13):3743-54. PubMed ID: 21556952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.